G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer

73Citations
Citations of this article
135Readers
Mendeley users who have this article in their library.

Abstract

The G protein-coupled estrogen receptor (GPER) is a seven-transmembrane-domain receptor that mediates non-genomic estrogen related signaling. After ligand activation, GPER triggers multiple downstream pathways that exert diverse biological effects on the regulation of cell growth, migration and programmed cell death in a variety of tissues. A significant correlation between GPER and the progression of multiple cancers has likewise been reported. Therefore, a better understanding of the role GPER plays in cancer biology may lead to the identification of novel therapeutic targets, especially among estrogen-related cancers. Here, we review cell signaling and detail the functions of GPER in malignancies.

Cite

CITATION STYLE

APA

Xu, S., Yu, S., Dong, D., & Lee, L. T. O. (2019, October 25). G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer. Frontiers in Endocrinology. Frontiers Media S.A. https://doi.org/10.3389/fendo.2019.00725

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free